P: population |
Adults (age >18 years) affected by nonmetastatic HNSCC (nasopharynx; oral cavity; oropharynx; hypopharynx, larynx; nasal cavity; and paranasal sinus); salivary gland cancer |
Pediatric patients (age < 18); non-HNSCC primary tumors; metastatic HNSCC cancer; and diagnosis of cutaneous squamous cell carcinoma or basal cell carcinoma of HNSCC |
“Head and neck tumor”/exp OR “head and neck cancer”/exp |
Head and neck tumor |
|
I: intervention |
Radiomics with artificial intelligence; radiomics-based machine-learning methods; and quantative radiographic phenotype analysis |
Exclusion of radiomic analysis from the machine-learning method (exclusive analysis of biomarkers, genetic profiles, clinical data, etc.) |
“Radiomics”/exp OR “machine learning”/exp |
Radiomics OR machine learning |
|
C: comparison |
(Not explored) |
|
|
|
|
O: outcome |
Radiation-induced toxicity; radiation-induced toxicity risk |
Prediction of survival outcomes; local disease response; prediction of HPV-status or nodal status; and automatic contouring implementation |
“Radiation toxicity”/exp OR “radiation tolerance”/exp OR'radiation injury'/exp |
Radiation toxicity/radiation tolerance/radiation injury |